D-0242-2021 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0242-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jan 11, 2021 and is designated Class III. Reason for recall: Incorrect Labeling: Incorrect lot number on secondary packaging The recall status is terminated (terminated Nov 2, 2021). Affected quantity: 36,275 cartons.

Recall details

Product Type
Drugs
Report Date
Feb 3, 2021
Initiation Date
Jan 11, 2021
Termination Date
Nov 2, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
36,275 cartons

Product description

Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

Reason for recall

Incorrect Labeling: Incorrect lot number on secondary packaging

Distribution pattern

Nationwide

Code information

Lot JKX2553A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0242-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0242-2021. Report a data issue: hello@regdatalab.com.